Forefront Collaborative, an ACCME-accredited independent healthcare education company, in partnership with MadMicrobe Studios and Vectorform, is proud to announce the next chapter for its ImmerseRX augmented reality (AR) app: a metastatic non-small cell lung cancer (mNSCLC) immersive learning experience.
Healthcare professional learners can pinch and zoom to scale, raise, and rotate 3D models to learn more about tumor immune evasion pathways, immunotherapy, and the pathological diagnosis and testing needed before an optimal treatment decision for patients with mNSCLC.
Also Read: Digital Transformation is Done
This collaboration exemplifies a “whole is greater than the sum of its parts” best-in-class collective, with medically rigorous content from Forefront Collaborative; stunning 3D visualization from MadMicrobe Studios; pioneering augmented reality (AR) app development from Vectorform; and input from expert faculty Dr. Sandip Patel (University of California San Diego) and Dr. Kurt Schalper (Yale School of Medicine).
“The ImmerseRX mNSCLC experience represents a tangible advance in scientific learning,” said Ro Brual, RPh, Senior Vice President and General Manager, Forefront Collaborative. “We see AR in gaming, but this is a first for the metastatic non-small cell lung cancer CME space. That’s good news for patients.”
SOURCE: PR Newswire